InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,899.83
(
1.61%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: powerbattles post# 97094

Monday, 10/30/2017 10:37:23 AM

Monday, October 30, 2017 10:37:23 AM

Post# of 97237
CTXR 3.37 +15%. cash/ share around $4.8 (About $35m cash, financing completed, raised $27m recently) vs only $22m marker cap. w/ near term Catalysts for both Phase 2 and Phase 3.

CTXR up 10% on Friday. Way undervalued.

Lead product (Mino-Lok)..has been granted QIDP, and is in Phase 3. There is no approved competition nor any on the horizon. 

Article 1. https://www.gurufocus.com/news/571266/why-citius-pharmaceuticals-looks-undervalued ;

Article 2 catalysts per Seeking Alpha https://seekingalpha.com/amp/article/4110554-promising-developments-citius-pharma

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up